![Yuval Cohen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yuval Cohen
Algemeen Directeur bij
CORBUS PHARMACEUTICALS HOLDINGS, INC.
Vermogen: 131 401 $ op 30-09-2026
Profiel
Yuval Cohen was the founder of Celsus Therapeutics Plc, founded in 2005, and held the title of Director & Senior Vice President in 2013.
Dr. Cohen currently holds the positions of Chief Executive Officer & Director at Corbus Pharmaceuticals, Inc. since 2013, and Chief Executive Officer & Director at Corbus Pharmaceuticals Holdings, Inc. since 2014.
Dr. Cohen's education includes an undergraduate degree from the University of Cape Town and a doctorate from Université de Paris 5 René Descartes.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 07-08-2026 | 19.267 ( 0,1% ) | 131 401 $ | 30-09-2026 |
Actieve functies van Yuval Cohen
| Bedrijven | Functie | Begin |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Algemeen Directeur | 11-04-2014 |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Algemeen Directeur | 01-07-2013 |
Eerdere bekende functies van Yuval Cohen
| Bedrijven | Functie | Einde |
|---|---|---|
Celsus Therapeutics Plc
 Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops novel non steroidal anti-inflammatory drugs | Oprichter | 01-12-2013 |
Opleiding van Yuval Cohen
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
43
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops novel non steroidal anti-inflammatory drugs | Health Technology |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
University of Cape Town
 University of Cape Town Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université de Paris 5 René Descartes
 Université de Paris 5 René Descartes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
